Mabcure Stock Odds of Future Pink Sheet Price Finishing Over 1.0E-4

MBCI Stock  USD 0.0001  0.00  0.00%   
MabCure's future price is the expected price of MabCure instrument. It is based on its current growth rate as well as the projected cash flow expected by the investors. This tool provides a mechanism to make assumptions about the upside potential and downside risk of MabCure performance during a given time horizon utilizing its historical volatility. Check out MabCure Backtesting, MabCure Valuation, MabCure Correlation, MabCure Hype Analysis, MabCure Volatility, MabCure History as well as MabCure Performance.
  
Please specify MabCure's target price for which you would like MabCure odds to be computed.

MabCure Alerts and Suggestions

In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of MabCure for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for MabCure can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.
MabCure generated a negative expected return over the last 90 days
MabCure has some characteristics of a very speculative penny stock
MabCure has a very high chance of going through financial distress in the upcoming years
MabCure currently holds 304.98 K in liabilities with Debt to Equity (D/E) ratio of 0.08, which may suggest the company is not taking enough advantage from borrowing. MabCure has a current ratio of 0.17, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Debt can assist MabCure until it has trouble settling it off, either with new capital or with free cash flow. So, MabCure's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like MabCure sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for MabCure to invest in growth at high rates of return. When we think about MabCure's use of debt, we should always consider it together with cash and equity.
The entity reported the previous year's revenue of 500 K. Net Loss for the year was (12.26 M) with profit before overhead, payroll, taxes, and interest of 500 K.
MabCure currently holds about 146.44 K in cash with (61.39 K) of positive cash flow from operations.

MabCure Price Density Drivers

Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of MabCure Pink Sheet often depends not only on the future outlook of the current and potential MabCure's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. MabCure's indicators that are reflective of the short sentiment are summarized in the table below.
Common Stock Shares Outstanding62.1 M
Cash And Short Term Investments146.4 K

MabCure Technical Analysis

MabCure's future price can be derived by breaking down and analyzing its technical indicators over time. MabCure Pink Sheet technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of MabCure. In general, you should focus on analyzing MabCure Pink Sheet price patterns and their correlations with different microeconomic environments and drivers.

MabCure Predictive Forecast Models

MabCure's time-series forecasting models is one of many MabCure's pink sheet analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary MabCure's historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the pink sheet market movement and maximize returns from investment trading.

Things to note about MabCure

Checking the ongoing alerts about MabCure for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for MabCure help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
MabCure generated a negative expected return over the last 90 days
MabCure has some characteristics of a very speculative penny stock
MabCure has a very high chance of going through financial distress in the upcoming years
MabCure currently holds 304.98 K in liabilities with Debt to Equity (D/E) ratio of 0.08, which may suggest the company is not taking enough advantage from borrowing. MabCure has a current ratio of 0.17, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Debt can assist MabCure until it has trouble settling it off, either with new capital or with free cash flow. So, MabCure's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like MabCure sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for MabCure to invest in growth at high rates of return. When we think about MabCure's use of debt, we should always consider it together with cash and equity.
The entity reported the previous year's revenue of 500 K. Net Loss for the year was (12.26 M) with profit before overhead, payroll, taxes, and interest of 500 K.
MabCure currently holds about 146.44 K in cash with (61.39 K) of positive cash flow from operations.

Other Information on Investing in MabCure Pink Sheet

MabCure financial ratios help investors to determine whether MabCure Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in MabCure with respect to the benefits of owning MabCure security.